Zemplar

Zemplar (Paricalcitol) is a vitamin D analog used to manage secondary hyperparathyroidism in chronic kidney disease. This oral medication helps regulate calcium and phosphorus levels. Suitable for patients on dialysis or with stage 3-5 CKD. Short-term use only.

Paricalcitol is primarily used to treat secondary hyperparathyroidism in adults with chronic kidney disease. It works by reducing elevated parathyroid hormone levels, which can otherwise weaken bones and cause other complications. The medication is often prescribed when phosphate binders and diet adjustments are insufficient. It may also be used off-label for certain vitamin D deficiency-related conditions under medical supervision.

Paricalcitol helps maintain balanced calcium and phosphorus levels in the blood, supporting bone health. Users may notice improved energy levels and reduced symptoms like muscle weakness or bone pain over time. Some individuals report better appetite and overall well-being with consistent use. Effects vary by individual and underlying health conditions.

Store Zemplar at room temperature away from moisture and heat. Keep the medication in its original container, tightly closed. Do not use if the packaging is damaged or the tablets appear discolored. Always check the expiration date before use. If you miss a dose, take it as soon as you remember, but skip it if it’s almost time for the next dose. Consult a healthcare provider before starting or stopping this medication.

Paricalcitol may interact with other medications that affect calcium levels, such as calcium supplements or thiazide diuretics. Cholestyramine and other drugs that reduce fat absorption can decrease its effectiveness. Inform your doctor about all prescription, over-the-counter, and herbal products you use. Alcohol and grapefruit juice may also influence how the medication works in your body.